T1	Phenotype	10 28	Expression of NQO1
T2	Pharmacodynamic_phenotype	48 72	sensitivity to 17-AAG in
T3	Disease	77 86	OSCC cell
T4	Phenotype	138 146	HSP90 at
T5	Pharmacodynamic_phenotype	177 198	resistant to 17-AAG .
R1	increases	Arg1:T1	Arg2:T2
R2	increases	Arg1:T1	Arg2:T3
R3	decreases	Arg1:T1	Arg2:T4
R4	increases	Arg1:T1	Arg2:T5
R5	increases	Arg1:T2	Arg2:T1
R6	treats	Arg1:T2	Arg2:T3
R7	decreases	Arg1:T2	Arg2:T4
R8	increases	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T1
R10	increases	Arg1:T3	Arg2:T2
R11	decreases	Arg1:T3	Arg2:T4
R12	isAssociatedWith	Arg1:T3	Arg2:T5
R13	isAssociatedWith	Arg1:T4	Arg2:T1
R14	increases	Arg1:T4	Arg2:T2
R15	isAssociatedWith	Arg1:T4	Arg2:T3
R16	isAssociatedWith	Arg1:T4	Arg2:T5
R17	isAssociatedWith	Arg1:T5	Arg2:T1
R18	increases	Arg1:T5	Arg2:T2
R19	treats	Arg1:T5	Arg2:T3
R20	isAssociatedWith	Arg1:T5	Arg2:T4
